Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 90 count NDC 43547-331-09
Published February 6, 2019 · Recall initiated: January 18, 2019
Summary
FDA records drug Class II recall D-0412-2019, published February 6, 2019 and initiated January 18, 2019. Recalling firm: Prinston Pharmaceutical Inc; Status: Completed; Reported quantity: 12294 bottles; Lot: 327B18008 327B18009. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
What to do
Voluntary: Firm initiated · Letter
Get an email if IRBESARTAN AND HYDROCHLOROTHIAZIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IRBESARTAN AND HYDROCHLOROTHIAZIDE
- Manufacturer
- Prinston Pharmaceutical Inc
- Distributor
- Nationwide
- UPC
- 0343547331030
- Lot
- 327B18008 327B18009
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIrbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang HuahaiFebruary 6, 2019
- FDAGENTAMICIN OPTH-SOL 5ml Compare: Garamycin. 5-mL plastic dropper bottle, Mfg: AKORN 17478-0283-10. NDCFebruary 6, 2019
- FDAIrbesartan Tablets 300 mg 90 count Rx only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao,February 6, 2019
- FDAProgesterone 10% cream, 12gm to 30gm per prescription, Rx only, Duren's Health Mart Pharmacy 215 Dexter WoodsFebruary 6, 2019
- FDAID Circuit Watertrap (P) 180, Catalog Number MP01341 Breathing Circuits/Anesthesia Sets without a Water trap:January 30, 2019
- FDAIrbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang HuahaiJune 29, 2016
Questions about this recall
Was Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 90 count NDC 43547-331-09 recalled?
Yes. FDA published recall D-0412-2019 on February 6, 2019. Reported hazard: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IRBESARTAN AND HYDROCHLOROTHIAZIDE. UPC: 0343547331030.